Design and Assessment of a Polyurethane Carrier Used for the Transmembrane Transfer of Acyclovir
Open Access
- 28 December 2020
- journal article
- research article
- Published by MDPI AG in Nanomaterials
- Vol. 11 (1) , 51
Abstract
The Herpes simplex viruses (HSV-1, HSV-2) are responsible for a wide variety of conditions, from cutaneous-mucosal to central nervous system (CNS) infections and occasional infections of the visceral organs, some of them with a lethal end. Acyclovir is often used intravenously, orally, or locally to treat herpetic infections but it must be administered with caution to patients with kidney disease and to children of early age. The main objectives of this study were to synthesize and evaluate new polyurethane nanoparticles that might be used as proper transmembrane carriers for acyclovir. Polyurethane particles were obtained by a polyaddition process: a mixture of two aliphatic diisocyanates used as organic phase was added to a mixture of butanediol and polyethylene glycol used as aqueous phase. Two different samples (with and without acyclovir, respectively) were synthesized and characterized by UV-Vis spectra in order to assess the encapsulation efficacy and the release profile, FT-IR, DSC, SEM, and SANS for structural characterization, as well as skin irritation tests. Nearly homogeneous samples with particle sizes between 78 and 91 nm have been prepared and characterized revealing a medium tendency to form clusters and a high resistance to heat up to 300 °C. The release profile of these nanoparticles is characteristic to a drug delivery system with a late discharge of the loaded active agents. Very slight increases in the level of transepidermal water loss and erythema were found in a 15-day evaluation on human skin. The results suggest the synthesis of a non-irritative carrier with a high encapsulation efficacy that can be successfully used for the transmembrane transfer of acyclovir.Keywords
Funding Information
- “Victor Babes” University of Medicine and Pharmacy, Timişoara, Romania (5EXP/1244/30.01.2020)
This publication has 46 references indexed in Scilit:
- Systemic Side Effects of Antiviral Therapy in a Patient with Acute Retinal NecrosisOcular Immunology and Inflammation, 2013
- Influence of emulsifiers on the characteristics of polyurethane structures used as drug carrierBMC Chemistry, 2013
- Polyurethane heart valves: past, present and futureExpert Review of Medical Devices, 2011
- Aciclovir neurotoxicity is an important side effect of therapy in patients with renal impairmentClinical Medicine, 2009
- Multiparticulate Drug Delivery Systems for Controlled ReleaseTropical Journal of Pharmaceutical Research, 2008
- Synthesis and characterization of cross-linked malonylchitosan microspheres for controlled release of acyclovirCarbohydrate Polymers, 2008
- In vivo resorption of a biodegradable polyurethane foam, based on 1,4‐butanediisocyanate: A three‐year subcutaneous implantation studyJournal of Biomedical Materials Research Part A, 2007
- Multiple Interactions of Cimetidine and Probenecid with Valaciclovir and Its Metabolite AcyclovirAntimicrobial Agents and Chemotherapy, 2002
- Skin barrier function in healthy volunteers as assessed by transepidermal water loss and vascular response to hexyl nicotinate: intra- and inter-individual variabilityBritish Journal of Dermatology, 1993
- Segmented polyurethane: A polyether polymer. An initial evalution for biomedical applicationsJournal of Biomedical Materials Research, 1968